Takayasu’s arteritis associated with Crohn’s disease treated with infliximab
Springer Science and Business Media LLC - Trang 1-5 - 2024
Tóm tắt
A 23-year-old woman presented with fever, diarrhea, bloody stools, and arthralgia that did not improve despite previous treatments and was diagnosed with Crohn’s disease. Remission was achieved after the introduction of infliximab, nutritional therapy, and 5-aminosalicylic acid treatment. However, the patient’s blood sedimentation rate remained elevated without symptom recurrence, except for abdominal pain in the following year. Aortic wall thickening in the thoracic descending aorta was also observed on computed tomography. Accumulation in the thoracic descending aorta and abdominal aorta was confirmed using positron emission tomography–computed tomography. The patient was diagnosed with Takayasu’s arteritis. The patient’s abdominal symptoms resolved, and her blood sedimentation rate normalized after steroid administration.
Tài liệu tham khảo
Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380:1590–605.
Hata A, Noda M, Moriwaki R, et al. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996;54(Suppl):S155–63.
de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83.
Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55:481–6.
Yassinger S, Adelman R, Cantor D, et al. Association of inflammatory bowel disease and large vascular lesions. Gastroenterology. 1976;71:844–6.
Reny JL, Paul JF, Lefèbvre C, et al. Association of Takayasu’s arteritis and Crohn’s disease. Results of a study on 44 Takayasu patients and review of the literature. Ann Med Interne (Paris). 2003;154:85–90.
Farrant M, Mason JC, Wong NA, et al. Takayasu’s arteritis following Crohn’s disease in a young woman: any evidence for a common pathogenesis? World J Gastroenterol. 2008;14:4087–90.
Kusunoki R, Ishihara S, Sato M, et al. rare case of Takayasu’s arteritis associated with Crohn’s disease. Intern Med. 2011;50:1581–5.
Yilmaz N, Can M, Alibaz-Oner F, et al. Clinically silent Crohn’s disease in a patient with Takayasu’s arteritis unresponsive to conventional therapies. Rheumatol Int. 2013;33:3091–3.
Pallone F, Monteleone G. Mechanisms of tissue damage in inflammatory bowel disease. Curr Opin Gastroenterol. 2001;17:307–12.
Terao C, Matsumura T, Yoshifuji H, et al. Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis Rheumatol. 2015;67:2226–32.
Akiyama S, Fujii T, Matsuoka K, et al. Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis. J Gastroenterol Hepatol. 2017;32:1011–7.
Simon S, Schittko G, Bösenberg H, et al. Fulminant course of a Takayasu’s arteritis and rare mesenteric arterial maninfestion. Z Rheumatol. 2006;65:522–6.
Tripathy NK, Gupta PC, Nityanand S. High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu’s arteritis. Clin Immunol. 2006;118:154–8.
Seko Y. Giant cell and Takayasu arteritis. Curr Opin Rheumatol. 2007;19:39–43.
Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn’s disease activity index National cooperative Crohn’s disease study. Gastroenterology. 1976;70:439–44.
Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–53.
Sy A, Khalidi N, Dehghan N, et al. Vasculitis in patients with inflammatory bowel diseases: a study of 32 patients and systematic review of the literature. Semin Arthritis Rheum. 2016;45:475–82.
Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–17.
Hall S, Barr W, Lie JT, et al. Takayasu’s arteritis. A study of 32 North American patients. Medicine. 1985;64:88–99.
Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919–29.
Nakaoka Y, Isobe M, Tanaka Y, et al. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. Rheumatology (Oxford). 2020;59:2427–34.
Domènech E, Garcia-Planella E, Olazábal A, et al. Abdominal aortitis associated with Crohn’s disease. Dig Dis Sci. 2005;50:1122–3.
Kellermayer R, Jain AK, Ferry G, et al. Clinical challenges and images in GI. Aortitis as a rare complication of Crohn’s disease. Gastroenterology. 2008;134:668–9.
El-Matary W, Persad R. Takayasu’s aortitis and infliximab. J Pediatr. 2009;155:151.
Katoh N, Kubota M, Shimojima Y, et al. Takayasu’s arteritis in a patient with Crohn’s disease: an unexpected association during infliximab therapy. Intern Med. 2010;49:179–82.
Ratuapli S, Mazlumzadeh M, Gurudu S, et al. Coexisting Crohn’s disease and Takayasu’s arteritis in two patients treated with Anti-TNF-α therapies. Case Rep Gastroenterol. 2010;4:35–40.
Osman M, Aaron S, Noga M, et al. Takayasu’s arteritis progression on anti-TNF biologics: a case series. Clin Rheumatol. 2011;30:703–6.
Miyakawa M, Tanaka H, Yamashita M, et al. A case of Takayasu’s arteritis detected in a patient with Crohn’s disease following infliximab treatment. Nihon Shokakibyo Gakkai Zasshi. 2016;113:1761–8.
Talathi S, Mannion M, Colvin E, et al. Aortitis with an Aneurysm at initial presentation of Crohn disease. J Pediatr Gastroenterol Nutr. 2018;67:e12–3.
Takeuchi I, Kawai T, Nambu M, et al. X-linked inhibitor of apoptosis protein deficiency complicated with Crohn’s disease-like enterocolitis and Takayasu arteritis: a case report. Clin Immunol. 2020;217: 108495.
Kollen L, Werner O, Gavotto A. Uncommon cause of chest pain in a 9-year-old boy with Crohn’s disease. Gastroenterology. 2020;158:2055–7.
Polyakova I, Iannucci G, George R, et al. Simultaneous presentation of Crohn’s disease and Takayasu arteritis in a teenage patient. J Investig Med High Impact Case Rep. 2020;8:2324709620977317.